Exact Sciences expects to double number of Cologuard tests completed in 2016

More than 100,000 Cologuard tests were completed by the end of 2015, but Exact Sciences expects the number of its stool DNA-based colorectal cancer screening tests completed in 2016 will more than double, according to a Post Bulletin report.

In addition to the growth in tests performed, Exact Sciences, based in Madison, Wis., is planning to build a new location in Madison. The $200 million project, which includes $46.7 million in public investment, is expected to add 400 jobs to the city, according to the report. Exact Sciences currently has more than 700 employees, with 275 hired in 2015.

More articles on gastroenterology:
FDA clears 5 GI/endoscopy devices in December
GPO Premier awards EndoChoice 3-year contract
Gastroenterologist Dr. Daniel Paulo dies at 82

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months